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An ultra-low dose (IO-‘” M) of opioid peptide [D-Ala’Jmethioninc enkcphalinamide (DAMEA) is found to exert an inhibitory effect on the 
production of reactive oxygen species (respiratory burst) in human neutrophils. The validity of this phenomenon has been verified in a series of 
studies that comprised 30 experiments. The inhibition has proved to be statistically significant (P<O.OOl). The dose-response dependence of the 
effect (10-‘5-10-’ M) followed a characteristic biphasic pattern (with the maximum effect at ultra-low doses). An opioid antagonist, naloxone 
partially blocks the inhibitory effect, which indicates that the DAMEA action is at least partially mediated by opioid receptors. 
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1. INTRODUCTION 
This paper deals with the effect of ultra-low doses of 
that at least some part of the DAMEA action is 
mediated by specific opioid receptors. 
a stable methionine enkephalin analog. [D-Ala’]- 
methionine enkephalinamide (DAMEA), on the pro- 
duction of reactive oxygen species (respiratory burst) in 
human neutrophils. The other types of opioid peptides, 
namely p-endorphin and dynorphin, were found to 
stimulate the respiratory burst in neutrophils at 10-12- 
lo-” M [l]. In our experiments he inhibitory effect of 
DAMEA on the respiratory burst was observed at 
ultra-low doses, a phenomenon that has many question 
marks to it. Indeed, in spite of the recent communica- 
tions on rhe effects by ultra-low doses (10-‘7-10-‘4 M) 
of different agents on biological objects [2-4], many, if 
not the majority, of researchers consider these effects 
hardly probable because of unusually low number of 
acting molecules contained in an experimental volume 
(102-IO’ in 0.1-l ml). 
2. MATERIALS AND METHODS 
2. I. Materids 
fMLP and luminol (5.amino-2,3-dihydro-1,4-phthalazinedione) 
were from Sigma; DANEA and naloxone were from Peptide Institute 
Inc. (Japan); HEPES was from Fluka; Dextran T-500 and Ficoll- 
Paque were obtained from Pharmacia. 
2.2. Soldons 
PBS: K&PO,, 0,144 p/l, NaCI, 9 d/I, Na,WPO,, 0.795 g/l. HBSS, 
pi-i 7.4, with the addition of 20 mM HEPES. was prepared from a 
concentrated stock solution of MBSS (Sigma) without Phenol red and 
bicarbonate. 
2.3. IW~(II/LW of rmtroplrils 
The procedure was the same as dcscribcd earlier [S]. The fraction 
ofpolymorphonuclear leukocytes (neutrophils) was kept on ice (4OC). 
A scrics of 10-l 5 experiments (luminescent studies) were started about 
2 h after the adaptation of cells to post-isolation conditions. 
We have looked into the effect induced by ultra-low 
doses of DAMEA on the respiratory burst in human 
neutrophils (evoked by chemotactic peptide formyl- 
methionylleucylphenylalanine, fRlLP). The inhibitory 
effect of 1O”4 M DAMEA on the respiratory burst was 
proven to be statistically valid. Administration of 
naloxone, an opioid receptor antagonist, partially 
abolishes the inhibitory effect of enkephalin; this means 
Ahhrel~icrlicrtrs: DAMEA, [D-Alit2]mcthiottilIc cnkcpllalinamidc; 
IMLP, formyl~aethionyllcl~cylpllcllylnlani~ic; liOS, rcactivc oxygen 
specks, 
The lcvcl of active oxygen gcncration by neutrophils was assayed 
by measuring the Iuainol-cnllanced lumincsccnce [6J in a luminometcr 
LKB 1251. Luminol at a final concentration of I PM was placed into 
a luminomctcr polystyrcnc cuvettc thermostatted at 37°C; DAMEA 
and (I-2)~lO”cclls (kept at 4°C prior to that) wcrc ad&d, and sponta- 
ncous chcmilumincsccncc was rccordcd for 4-5 min: thcrcupon fMLP 
(IO-’ M) was added. The response was rccordcd in mV. In each 
cxpcrimcnt simultaneous readings of 4-6 cuvcttcs were rccordcd, half 
ofthc number containing the control solution. and the other half the 
cffcctor (DAMEA). Results wcrc cxprcsscd ;I$ the ratio of mean 
ehcmilumincsccrlcc with DAMEA to that without. 
‘The rcsuks ofcxpcrinlcnts wcrc proccsscd using thcSigmaplot v.4,O 
program (Jan&l Scicntiiic) an an IBM PC. Confidence ietcrvals wcrc 
dctcrmincd by Student’s I-test, the reliability of cffccl was cstimatcd 
ul.ro by the nonq~aramctric sign fcrt, 
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Time ofter FMLP addition (set) 
Fig. 1. Time course of the respiratory burst in human neutrophils (as 
luminol-enhanced luminescence) evoked by lo-’ M fMLP with (2) or 
without (1) addition of IO-l4 hl DAMEA. 
3. RESULTS AND DISCUSSION 
Typical curves showing the DAMEA effect on the 
kinetics of reactive oxygen species @OS) generation 
(presented as luminsl-enhanced luminescence) are re- 
presented in Fig. 1. The administration of enkephalin 
in a dose of lo-l4 M results in a decrease both in the 
maximal rate of ROS generation and in the total 
amount of reactive oxygen generated (the integral below 
the curve). Wowever, only a minor effect of 15-20% is 
observed. 
There are some common regularities and problems in 
experiments with ultra-low doses. (1) Acting concentra- 
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Fig. 2, Dokc dcpcodcncc of the DAMEA cffcct in 5% with rcspcct to 
controts. nicm vnlua SAW% conhle~w intervals (30 rcplicetcs 10”‘d 
M. 5 to 9 replicates for other concentrations). Lch bitrk, the cfkt ofi 
the maximal rate of KOS gcncri~tion; right bars, on the totd attloUt?t 
I& (which in our case is about lo-* M [7]); this makes 
it difficult to explain the observed effects from a conven- 
tional standpoint. (2) The absence, as a rule, of the 
effects when usual (comparable to K,,, K,,,) doses of the 
same compounds are used, or the presence of opposite 
effects at higher doses. (3) The poor reproduction of 
ultra-low dose effects, which does not make it possible 
to apply conventional criteria to validate the statistical 
significance of the phenomenon [2-4]. 
Therefore, we tested the validity of the phenomenon 
with special attention. The results indicate that lQ-‘4 M 
DAMEA inhibits the maximal rate of ROS generation 
in 26 out of 30 experiments. The effect was observed in 
neutrophils of all blood donors (n=6). In some cases the 
effect value was as high as 40-W&. The inhibitory effect 
proved to be statistically significant according to both 
the sign test and Student’s z-test (JW.001). 
A comparative analysis of the peptide ffect on sepa- 
rate parts of the normalized kinetic curve (divided by 
the maximal response) enabled us to conclude that lo-l4 
M DAMEA also slightly decreases the rate of inactiva- 
tion of ROS generation (displayed as the less steep de- 
cline at the descending part of curve 2 when compared 
to curve 1, Fig. 1). Although the observed effect is 
minor, it is significant according to the sign test 
(PcO.01, 30 replicates). 
Studies on the DANEA effect over a wide range of 
concentrations (Fig. 2) have shown that the dose-re- 
sponse dependence is of an ‘inverse bell’ shape, which 
is characteristic of the ultra-low dose effects described 
in t.he literature [2-4]. The respiratory burst inhibition 
is observed at iO-!“- IO-” M but absent at lo-” and 10s9 
M. There is a good correlation between DAMEA effects 
on the maximal rate of ROS generation and on the total 
amount of RO§ generated uring the experiment (left 
and right bars). 
To test the specificity of DAMEA effects, we studied 
the action of DAMEA amino acids (tyrosine and me- 
thionine in particular), capable of comparatively simple 
oxidation-reduction transformations, and of the opioid 
antagonist naloxone on the respiratory burst, Neither 
tyrosine nor methionine (nor other DAMEA amino 
acids) in lo-l4 M doses inhibit the respiratory burst in 
neutrophils (data not shown). Naloxone at 10s7 M par- 
tially blocks the 10 -I4 M DAMEA effect - the value 
of the DAMEA inhibitory effect in the presence of nalo- 
xone is 6.254.6% (mean rt95% confidence intervals) 
which is significantly (P~0.01) lower than the effect 
without naloxone (15.5+4,2%). Treatment with IO-’ M 
naloxone alone (without DAMEA) had no significant 
effect on respiratory burst (not shown). 
The main conclusion that may be drawn from this 
experimental study is that the met-enkephalin analog 
DAMEA in a dose of 10’14 M inhibits the respiratory 
burst in human neutrophils, the effect being statistically 
signilkmt with PcO.001. The inhibitory effect is not 
attributed to tyrosine or methionine, DAMEA molcculc 
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